Photo: Depositphotos.com
Jul 9, 2025, 19:55
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models – NCI Division of Cancer Biology
NCI Division of Cancer Biology shared on LinkedIn:
“An NIH-funded study showed that erythropoietin (a hormone that stimulates the production of red blood cells) secreted by tumor cells promotes an immunosuppressive tumor microenvironment in liver cancer models. It also found that blocking erythropoietin signaling enhances immune responses to tumors.”
Title: Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
Authors: David Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng, Qiang Liu, Kazukuni Hayashi, Bo Yu, Ryan Lee, Catherine Zhang, Xiuli An, Jayakumar Rajadas, Nathan E. Reticker-Flynn, Erinn B. Rankin, Edgar G. Engleman
Read an insightful article about Liver Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 16:53
Jul 27, 2025, 16:04
Jul 27, 2025, 15:38
Jul 27, 2025, 15:14
Jul 27, 2025, 15:03
Jul 27, 2025, 14:26